Literature DB >> 22395339

Relaxation of the rigid backbone of an oligoamide-foldamer-based α-helix mimetic: identification of potent Bcl-xL inhibitors.

Jeremy L Yap1, Xiaobo Cao, Kenno Vanommeslaeghe, Kwan-Young Jung, Chander Peddaboina, Paul T Wilder, Anjan Nan, Alexander D MacKerell, W Roy Smythe, Steven Fletcher.   

Abstract

By conducting a structure-activity relationship study of the backbone of a series of oligoamide-foldamer-based α-helix mimetics of the Bak BH3 helix, we have identified especially potent inhibitors of Bcl-x(L). The most potent compound has a K(i) value of 94 nM in vitro, and single-digit micromolar IC(50) values against the proliferation of several Bcl-x(L)-overexpressing cancer cell lines. This journal is © The Royal Society of Chemistry 2012

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22395339     DOI: 10.1039/c2ob07125h

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  24 in total

1.  Evaluating minimalist mimics by exploring key orientations on secondary structures (EKOS).

Authors:  Dongyue Xin; Eunhwa Ko; Lisa M Perez; Thomas R Ioerger; Kevin Burgess
Journal:  Org Biomol Chem       Date:  2013-10-14       Impact factor: 3.876

2.  Correlations between secondary structure- and protein-protein interface-mimicry: the interface mimicry hypothesis.

Authors:  Jaru Taechalertpaisarn; Rui-Liang Lyu; Maritess Arancillo; Chen-Ming Lin; Lisa M Perez; Thomas R Ioerger; Kevin Burgess
Journal:  Org Biomol Chem       Date:  2019-03-20       Impact factor: 3.876

Review 3.  Inhibition of α-helix-mediated protein-protein interactions using designed molecules.

Authors:  Valeria Azzarito; Kérya Long; Natasha S Murphy; Andrew J Wilson
Journal:  Nat Chem       Date:  2013-03       Impact factor: 24.427

4.  Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein.

Authors:  Maryanna E Lanning; Wenbo Yu; Jeremy L Yap; Jay Chauhan; Lijia Chen; Ellis Whiting; Lakshmi S Pidugu; Tyler Atkinson; Hala Bailey; Willy Li; Braden M Roth; Lauren Hynicka; Kirsty Chesko; Eric A Toth; Paul Shapiro; Alexander D MacKerell; Paul T Wilder; Steven Fletcher
Journal:  Eur J Med Chem       Date:  2016-02-04       Impact factor: 6.514

5.  Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics.

Authors:  Kwan-Young Jung; Huabo Wang; Peter Teriete; Jeremy L Yap; Lijia Chen; Maryanna E Lanning; Angela Hu; Lester J Lambert; Toril Holien; Anders Sundan; Nicholas D P Cosford; Edward V Prochownik; Steven Fletcher
Journal:  J Med Chem       Date:  2015-03-30       Impact factor: 7.446

6.  Towards more drug-like proteomimetics: two-faced, synthetic α-helix mimetics based on a purine scaffold.

Authors:  M E Lanning; P T Wilder; H Bailey; B Drennen; M Cavalier; L Chen; J L Yap; M Raje; S Fletcher
Journal:  Org Biomol Chem       Date:  2015-07-24       Impact factor: 3.876

Review 7.  Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.

Authors:  Xu Ran; Jason E Gestwicki
Journal:  Curr Opin Chem Biol       Date:  2018-06-13       Impact factor: 8.822

8.  BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells.

Authors:  Mariarita Perri; Jeremy L Yap; Jianshi Yu; Erika Cione; Steven Fletcher; Maureen A Kane
Journal:  Exp Cell Res       Date:  2014-08-01       Impact factor: 3.905

9.  Serine phosphorylation is critical for the activation of ubiquitin-specific protease 1 and its interaction with WD40-repeat protein UAF1.

Authors:  Mark A Villamil; Qin Liang; Junjun Chen; Yong Seok Choi; Shuyu Hou; Kelvin H Lee; Zhihao Zhuang
Journal:  Biochemistry       Date:  2012-11-01       Impact factor: 3.162

10.  Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted Nicotinates.

Authors:  Brandon Drennen; Jacob A Scheenstra; Jeremy L Yap; Lijia Chen; Maryanna E Lanning; Braden M Roth; Paul T Wilder; Steven Fletcher
Journal:  ChemMedChem       Date:  2016-02-04       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.